Financhill
Back

Intra-Cellular Therapies Vs. Insmed Industry Stock Comparison

Sell
40

ITCI
Intra-Cellular Therapies

Last Price:
66.50
Seasonality Move:
-0.94%
Sell
50

INSM
Insmed

Last Price:
24.91
Seasonality Move:
-5.11%
Sell
40
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $66.53. The Score for ITCI is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Insmed (INSM) is a Sell

Is Insmed a Buy, Sell or Hold?

  • The current Insmed [INSM] share price is $25.10. The Score for INSM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • INSM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $66.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing slight buying pressure.

INSM Stock Price Chart

What is Insmed's stock price today?

  • The Insmed share price today is $25.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INSM is experiencing slight buying pressure.

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.11 Sell
Relative Strength Index (14 RSI): 43.73 Sell
Chaikin Money Flow: 207665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.48 - 74.3) Sell
Bollinger Bands (100): (66.15 - 72.27) Sell

INSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 42.56 Sell
Chaikin Money Flow: 482989 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.81 - 26.29) Sell
Bollinger Bands (100): (25.92 - 29.08) Sell

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.76 Sell
20-day SMA: 70.02 Sell
50-day SMA: 68.75 Sell
200-day SMA: 62.74 Buy
8-day EMA: 67.09 Sell
20-day EMA: 68.63 Sell
50-day EMA: 69 Sell
200-day EMA: 64.65 Buy

INSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.72 Sell
20-day SMA: 25.37 Sell
50-day SMA: 26.35 Sell
200-day SMA: 26.17 Sell
8-day EMA: 25.48 Sell
20-day EMA: 25.69 Sell
50-day EMA: 26.28 Sell
200-day EMA: 25.72 Sell

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.08 per share, and an increase next year of $1.44 per share.

Insmed Earnings Growth & INSM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.81 per share, and an increase next year of $1.05 per share.

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Insmed Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):